The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Seminar Title
Seminar ER1: Clinical Trials in Paediatric Haemato-oncology: different ways for HPs to participate
Affiliation
Vienna General Hospital - Medical University Campus
Country
Austria
1. Current Status, Position
Mrs Aretin is currently coordinator for clinical trials, pharmacist in the cytotoxic compounding department and lead clinical pharmacist in oncology.
2. Education
Mrs Aretin attained her degree in Pharmacy in the University of Vienna in 2008 (Master Thesis: In-vitro and in-vivo analyses of Aprepitant, University of Vienna: Pharmacy studies). She did an internship in Pharmacy Germania-Apotheke in 2009 in Vienna, Austria.
3. Research Area
Her research is focused on investigational drugs (from first-in-human to phase III) and supportive care for cancer patients (especially antiemetics, skin toxicities).
4. Conflict of interest: none